Reference
Ohno-Matsui K, et al. Real-world data on ranibizumab for myopic choroidal neovascularization due to pathologic myopia: results from a post-marketing surveillance in Japan. Eye 32: 1871-1878, No. 12, Dec 2018. Available from: URL: http://doi.org/10.1038/s41433-018-0192-2 - Japan
Rights and permissions
About this article
Cite this article
Ranibizumab. Reactions Weekly 1736, 168 (2019). https://doi.org/10.1007/s40278-019-57061-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-019-57061-6